The global Genomics Personalized Health market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life
By Types:
NGS platforms
RT-PCR
Microarray
Genetic Analyzers
By Applications:
Academics & Research Institutes
Diagnostic Centers
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Genomics Personalized Health Market Size Analysis from 2023 to 2028
1.5.1 Global Genomics Personalized Health Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Genomics Personalized Health Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Genomics Personalized Health Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Genomics Personalized Health Industry Impact
Chapter 2 Global Genomics Personalized Health Competition by Types, Applications, and Top Regions and Countries
2.1 Global Genomics Personalized Health (Volume and Value) by Type
2.1.1 Global Genomics Personalized Health Consumption and Market Share by Type (2017-2022)
2.1.2 Global Genomics Personalized Health Revenue and Market Share by Type (2017-2022)
2.2 Global Genomics Personalized Health (Volume and Value) by Application
2.2.1 Global Genomics Personalized Health Consumption and Market Share by Application (2017-2022)
2.2.2 Global Genomics Personalized Health Revenue and Market Share by Application (2017-2022)
2.3 Global Genomics Personalized Health (Volume and Value) by Regions
2.3.1 Global Genomics Personalized Health Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Genomics Personalized Health Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Genomics Personalized Health Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Genomics Personalized Health Consumption by Regions (2017-2022)
4.2 North America Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
4.10 South America Genomics Personalized Health Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Genomics Personalized Health Market Analysis
5.1 North America Genomics Personalized Health Consumption and Value Analysis
5.1.1 North America Genomics Personalized Health Market Under COVID-19
5.2 North America Genomics Personalized Health Consumption Volume by Types
5.3 North America Genomics Personalized Health Consumption Structure by Application
5.4 North America Genomics Personalized Health Consumption by Top Countries
5.4.1 United States Genomics Personalized Health Consumption Volume from 2017 to 2022
5.4.2 Canada Genomics Personalized Health Consumption Volume from 2017 to 2022
5.4.3 Mexico Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 6 East Asia Genomics Personalized Health Market Analysis
6.1 East Asia Genomics Personalized Health Consumption and Value Analysis
6.1.1 East Asia Genomics Personalized Health Market Under COVID-19
6.2 East Asia Genomics Personalized Health Consumption Volume by Types
6.3 East Asia Genomics Personalized Health Consumption Structure by Application
6.4 East Asia Genomics Personalized Health Consumption by Top Countries
6.4.1 China Genomics Personalized Health Consumption Volume from 2017 to 2022
6.4.2 Japan Genomics Personalized Health Consumption Volume from 2017 to 2022
6.4.3 South Korea Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 7 Europe Genomics Personalized Health Market Analysis
7.1 Europe Genomics Personalized Health Consumption and Value Analysis
7.1.1 Europe Genomics Personalized Health Market Under COVID-19
7.2 Europe Genomics Personalized Health Consumption Volume by Types
7.3 Europe Genomics Personalized Health Consumption Structure by Application
7.4 Europe Genomics Personalized Health Consumption by Top Countries
7.4.1 Germany Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.2 UK Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.3 France Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.4 Italy Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.5 Russia Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.6 Spain Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.7 Netherlands Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.8 Switzerland Genomics Personalized Health Consumption Volume from 2017 to 2022
7.4.9 Poland Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 8 South Asia Genomics Personalized Health Market Analysis
8.1 South Asia Genomics Personalized Health Consumption and Value Analysis
8.1.1 South Asia Genomics Personalized Health Market Under COVID-19
8.2 South Asia Genomics Personalized Health Consumption Volume by Types
8.3 South Asia Genomics Personalized Health Consumption Structure by Application
8.4 South Asia Genomics Personalized Health Consumption by Top Countries
8.4.1 India Genomics Personalized Health Consumption Volume from 2017 to 2022
8.4.2 Pakistan Genomics Personalized Health Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Genomics Personalized Health Market Analysis
9.1 Southeast Asia Genomics Personalized Health Consumption and Value Analysis
9.1.1 Southeast Asia Genomics Personalized Health Market Under COVID-19
9.2 Southeast Asia Genomics Personalized Health Consumption Volume by Types
9.3 Southeast Asia Genomics Personalized Health Consumption Structure by Application
9.4 Southeast Asia Genomics Personalized Health Consumption by Top Countries
9.4.1 Indonesia Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.2 Thailand Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.3 Singapore Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.4 Malaysia Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.5 Philippines Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.6 Vietnam Genomics Personalized Health Consumption Volume from 2017 to 2022
9.4.7 Myanmar Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 10 Middle East Genomics Personalized Health Market Analysis
10.1 Middle East Genomics Personalized Health Consumption and Value Analysis
10.1.1 Middle East Genomics Personalized Health Market Under COVID-19
10.2 Middle East Genomics Personalized Health Consumption Volume by Types
10.3 Middle East Genomics Personalized Health Consumption Structure by Application
10.4 Middle East Genomics Personalized Health Consumption by Top Countries
10.4.1 Turkey Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.3 Iran Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.5 Israel Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.6 Iraq Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.7 Qatar Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.8 Kuwait Genomics Personalized Health Consumption Volume from 2017 to 2022
10.4.9 Oman Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 11 Africa Genomics Personalized Health Market Analysis
11.1 Africa Genomics Personalized Health Consumption and Value Analysis
11.1.1 Africa Genomics Personalized Health Market Under COVID-19
11.2 Africa Genomics Personalized Health Consumption Volume by Types
11.3 Africa Genomics Personalized Health Consumption Structure by Application
11.4 Africa Genomics Personalized Health Consumption by Top Countries
11.4.1 Nigeria Genomics Personalized Health Consumption Volume from 2017 to 2022
11.4.2 South Africa Genomics Personalized Health Consumption Volume from 2017 to 2022
11.4.3 Egypt Genomics Personalized Health Consumption Volume from 2017 to 2022
11.4.4 Algeria Genomics Personalized Health Consumption Volume from 2017 to 2022
11.4.5 Morocco Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 12 Oceania Genomics Personalized Health Market Analysis
12.1 Oceania Genomics Personalized Health Consumption and Value Analysis
12.2 Oceania Genomics Personalized Health Consumption Volume by Types
12.3 Oceania Genomics Personalized Health Consumption Structure by Application
12.4 Oceania Genomics Personalized Health Consumption by Top Countries
12.4.1 Australia Genomics Personalized Health Consumption Volume from 2017 to 2022
12.4.2 New Zealand Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 13 South America Genomics Personalized Health Market Analysis
13.1 South America Genomics Personalized Health Consumption and Value Analysis
13.1.1 South America Genomics Personalized Health Market Under COVID-19
13.2 South America Genomics Personalized Health Consumption Volume by Types
13.3 South America Genomics Personalized Health Consumption Structure by Application
13.4 South America Genomics Personalized Health Consumption Volume by Major Countries
13.4.1 Brazil Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.2 Argentina Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.3 Columbia Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.4 Chile Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.5 Venezuela Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.6 Peru Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Genomics Personalized Health Consumption Volume from 2017 to 2022
13.4.8 Ecuador Genomics Personalized Health Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Genomics Personalized Health Business
14.1 QIAGEN
14.1.1 QIAGEN Company Profile
14.1.2 QIAGEN Genomics Personalized Health Product Specification
14.1.3 QIAGEN Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Illumina
14.2.1 Illumina Company Profile
14.2.2 Illumina Genomics Personalized Health Product Specification
14.2.3 Illumina Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Thermo Fisher Scientific
14.3.1 Thermo Fisher Scientific Company Profile
14.3.2 Thermo Fisher Scientific Genomics Personalized Health Product Specification
14.3.3 Thermo Fisher Scientific Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Bio-Rad
14.4.1 Bio-Rad Company Profile
14.4.2 Bio-Rad Genomics Personalized Health Product Specification
14.4.3 Bio-Rad Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Roche
14.5.1 Roche Company Profile
14.5.2 Roche Genomics Personalized Health Product Specification
14.5.3 Roche Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Lonza
14.6.1 Lonza Company Profile
14.6.2 Lonza Genomics Personalized Health Product Specification
14.6.3 Lonza Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 INVITAE
14.7.1 INVITAE Company Profile
14.7.2 INVITAE Genomics Personalized Health Product Specification
14.7.3 INVITAE Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Genetic Technologies
14.8.1 Genetic Technologies Company Profile
14.8.2 Genetic Technologies Genomics Personalized Health Product Specification
14.8.3 Genetic Technologies Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Interleukin Genetics
14.9.1 Interleukin Genetics Company Profile
14.9.2 Interleukin Genetics Genomics Personalized Health Product Specification
14.9.3 Interleukin Genetics Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Eastern Biotech
14.10.1 Eastern Biotech Company Profile
14.10.2 Eastern Biotech Genomics Personalized Health Product Specification
14.10.3 Eastern Biotech Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 DNA Genotek
14.11.1 DNA Genotek Company Profile
14.11.2 DNA Genotek Genomics Personalized Health Product Specification
14.11.3 DNA Genotek Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 UBiome
14.12.1 UBiome Company Profile
14.12.2 UBiome Genomics Personalized Health Product Specification
14.12.3 UBiome Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 XCode Life
14.13.1 XCode Life Company Profile
14.13.2 XCode Life Genomics Personalized Health Product Specification
14.13.3 XCode Life Genomics Personalized Health Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Genomics Personalized Health Market Forecast (2023-2028)
15.1 Global Genomics Personalized Health Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Genomics Personalized Health Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Genomics Personalized Health Value and Growth Rate Forecast (2023-2028)
15.2 Global Genomics Personalized Health Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Genomics Personalized Health Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Genomics Personalized Health Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Genomics Personalized Health Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Genomics Personalized Health Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Genomics Personalized Health Consumption Forecast by Type (2023-2028)
15.3.2 Global Genomics Personalized Health Revenue Forecast by Type (2023-2028)
15.3.3 Global Genomics Personalized Health Price Forecast by Type (2023-2028)
15.4 Global Genomics Personalized Health Consumption Volume Forecast by Application (2023-2028)
15.5 Genomics Personalized Health Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 137 |